These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19261026)

  • 1. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
    De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
    Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.
    Sullivan TP; Dearaujo T; Vincek V; Berman B
    Dermatol Surg; 2003 Dec; 29(12):1181-6. PubMed ID: 14725659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.
    Urosevic M; Maier T; Benninghoff B; Slade H; Burg G; Dummer R
    Arch Dermatol; 2003 Oct; 139(10):1325-32. PubMed ID: 14568837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?
    RUIZ-VILLAVERDE R; SANCHEZ-CANO D; BURKHARDT-PEREZ P; SINTES RN
    Eur J Dermatol; 2009; 19(5):481-3. PubMed ID: 19527989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells.
    Huang SW; Liu KT; Chang CC; Chen YJ; Wu CY; Tsai JJ; Lu WC; Wang YT; Liu CM; Shieh JJ
    Br J Dermatol; 2010 Aug; 163(2):310-20. PubMed ID: 20426785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells.
    Barnetson RS; Satchell A; Zhuang L; Slade HB; Halliday GM
    Clin Exp Dermatol; 2004 Nov; 29(6):639-43. PubMed ID: 15550144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
    Berman B; Sullivan T; De Araujo T; Nadji M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
    Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
    Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
    J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
    Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
    Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.
    Pellegrini C; Orlandi A; Costanza G; Di Stefani A; Piccioni A; Di Cesare A; Chiricozzi A; Ferlosio A; Peris K; Fargnoli MC
    PLoS One; 2017; 12(8):e0183415. PubMed ID: 28829805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod in basal cell carcinoma: how does it work?
    Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
    Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.